{"name":"GenVec","slug":"genvec","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":3682000,"revenueGrowth":2439.3,"grossMargin":0,"rdSpend":2499000,"netIncome":-5787000,"cash":7707000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2013"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AdGVPEDF.11D","genericName":"AdGVPEDF.11D","slug":"adgvpedf-11d","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"AdGVPEDF.11D","genericName":"AdGVPEDF.11D","slug":"adgvpedf-11d","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1HdVgzbC1IT1JqWkdDYXFuWjlmOGxBZ2lYSE9nVFlqTFpsN2JOSVhJQUtwQmFnM1FXa21Hb2NDNVVtRjlvV2xGLTg3b0Y5bk1wYnlld0UtTDJxalVNVVdhejl5aXpvdw?oc=5","date":"2023-03-04","type":"pipeline","source":"GuruFocus","summary":"Michael Richman Net Worth (2026) - GuruFocus","headline":"Michael Richman Net Worth (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTFBad0tORGpXeERWY185WXhIWThDSEVha0ZQbHdiTnhDeURndWlfZmRtbUpkMnY3dGFhc1pFYjZhVmN2UzdfaGN6NzMtWEVfMXBhQmJvQThzLXpyNnFVelVGWg?oc=5","date":"2022-08-05","type":"pipeline","source":"Delawareonline.com","summary":"Thomas W. D’Alonzo Obituary - The News Journal - Delawareonline.com","headline":"Thomas W. D’Alonzo Obituary - The News Journal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQSUlTVG5OQ1Q4OGp1bXJXVlNBYjlGM1RYeWdmN0lRakNSNWNOQW9OcjM2Q1UyWFc4Y09fckN2aXhxc2lOQzRaUE5GVFJ5OHZtYTlvUGRwbS1DV3VUVml4ZVI0OUd3b1N1Z0VWdVNKb2Y0QTRUUGlaY192SGlvUThQNl9rejF0MEND?oc=5","date":"2020-12-09","type":"pipeline","source":"BioSpace","summary":"Top 16 Highest-Paid Women CEOs in the Biopharma Industry - BioSpace","headline":"Top 16 Highest-Paid Women CEOs in the Biopharma Industry","sentiment":"neutral"},{"date":"2017-06-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOcHFJbjRVc25ROVd4V05scjlTZHdpUlV5R1RSaHoxdlFaY2JqVkNnYm9kYjJ4MVoycjJnWi1rMmhoSEE5ak5oc1YtM2JYQndYdnBmLU1DTjNzNURvNnhnaW5QdkJpVHdwZm05YTdhMmFSNUFKcERDemRpb3BWdXpXQU8yMk9DTG1GRG9IZA?oc=5","date":"2017-01-26","type":"pipeline","source":"BioPharma Dive","summary":"Intrexon picks up struggling GenVec to build delivery tech - BioPharma Dive","headline":"Intrexon picks up struggling GenVec to build delivery tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMTZ4ZFI5Rm96bTFiNlNXc1dlaERnY3g0OUhCRzFHNXBfaG11bzI2ekxEMVp4Nko0SHJYa0s2UWdsbFZZN0dWZ0FZazFLcWl2Sjd1TDFNRm4wY3VjaXZzekl0ZlMtcFlIMVFWNEtCR2ptbWU0TjlBR2owNjRSVHM0dTZiWnJubzlzdmpFUTFmTjE4X1BobGhoQktOZw?oc=5","date":"2017-01-25","type":"deal","source":"Fierce Biotech","summary":"Intrexon to buy floundering GenVec for gene delivery tech - Fierce Biotech","headline":"Intrexon to buy floundering GenVec for gene delivery tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxPQ2RzS3Z2dDZjUGVoczZfNHhUb3hhSEx6VFZkU242MmJQMnJXTEF4UHdwOC1iaDdYcVZ1QlN3RDBlb1JFUzFIUjkyTVJrMFhkUlctdVF1TUgtQ1dJNy1fbS1WdVpKcllrT0tYNElZY3dqdEd3eFhGeVByUUN4ZjhKaDU1alFfZ1Q4dC12RDNFTVNVRHlSMWVvblk0OFQzSk9tXzlwZC00dlhJMkRBQUszWDdyM3o2SnZJYnNtMEczd2xBSUJxajBjUi14NS0?oc=5","date":"2017-01-24","type":"deal","source":"PR Newswire","summary":"Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform - PR Newswire","headline":"Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNMVQzZ0YyUEM4MDN0VHU2dDJ3RW9PR19DeV85RW10eU5NT29tc2dJa0t4TWo2c1Fjei1jb3BpendETUtZeEk0RmgwVTJVWlh1eXYtZTFIQUd5d3MxMEpoNUNYVEhGVnJQaFViSTJLc3lhR0FkUFl4MERQT0RnVy1nem94ZEIycG84UTR5OUp0QVNzdXhDOUZScDNJcmFXMXF6aFZ6MFpkQ3pSYjVNRlRaU05R?oc=5","date":"2016-10-14","type":"pipeline","source":"Bloomberg.com","summary":"Gels to Repair Hearing Loss? Drugmakers Try New Ear Treatments - Bloomberg.com","headline":"Gels to Repair Hearing Loss? Drugmakers Try New Ear Treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNc3Y5alRDbG4tSUFNWTdONlVRQlFuRzRienBCaDh4UllDX2tYQk5GM2xLQ1ROQVBxZGo2UUVVSkFRRGhBSXhUWENxYWdTM3pZYjk2QkhlVlZVWXhhX0hreGg1dXQydlgwWXgyTndwM0NwZ0tGU3hES2ZveTZCMHU2VFFaV0g3S0V4?oc=5","date":"2016-09-01","type":"pipeline","source":"Fierce Biotech","summary":"GenVec: We’re not a victim of Novartis R&D cuts - Fierce Biotech","headline":"GenVec: We’re not a victim of Novartis R&D cuts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNUE9rcm5jS0RncWRYYXJ1S3YtS1JXWldhN1BrTlA1aFlCTEVkb0tpNHZweUhmZDZkdG55RVI2QVJvSTY5S1F3WkpKdmVhcmUxUmlHYXl0OU5yWG1aTFVjRFY2dGV1YmYzNTFiR29jT0kyVXRyUmlMLWgyai0xems5U1o3UHVuTnVLTkZkaGdZZHMtZndxczJqekNidTVsWU0?oc=5","date":"2016-08-26","type":"pipeline","source":"Fierce Biotech","summary":"GenVec, encamped in penny-stock territory, risks Nasdaq delisting - Fierce Biotech","headline":"GenVec, encamped in penny-stock territory, risks Nasdaq delisting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQR0hnU3p1UEJDWE9mbEhYZWFBcE9oVUs2OVctRl92ZWwyVTRVMnV2QnBWb3BjWEljX052QXlCNW9zRzVndjM2S3BqYU9WM1A2a0RtQmV1a2VaM09nbmh4TUcyLXQ0YVMwcmRERW43ZUpSZHlMY0lSbUlqZ3FSeHRuc1ZGV3NoTUFPUjJtM01aakNTVG9mQXVlbGxVXzl6RDYwZmN2a1ZQV3F2M0tFNkQ4Ug?oc=5","date":"2016-07-25","type":"regulatory","source":"The Pharma Letter","summary":"FDA lifts clinical hold on GenVec/Novartis' CGF166 in hearing loss - The Pharma Letter","headline":"FDA lifts clinical hold on GenVec/Novartis' CGF166 in hearing loss","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar","revenue":3682000,"revenuePeriod":"2013-12-31","revenueHistory":[{"value":3682000,"period":"2013-12-31"},{"value":145000,"period":"2013-12-31"},{"value":1582000,"period":"2013-09-30"},{"value":748000,"period":"2013-06-30"},{"value":1207000,"period":"2013-03-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":2499000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-5787000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":7707000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}